Russian scientist Denis Logunov, a lead developer of the Sputnik V coronavirus vaccine, said on Friday that the shot had proven itself 97.6 percent effective against COVID-19 in a real-world assessment, based on data from 3.8 million people.
The new effectiveness rate is higher than the 91.6 percent rate outlined in results from a large-scale trial of Sputnik V and published in The Lancet medical journal earlier this year.
Using a database of people who received both doses of the vaccine, scientists at Moscow’s Gamaleya Institute, which developed it, calculated a real-world effectiveness rate of 97.6 percent, Logunov said during a presentation for the Russian Academy of Sciences.
S.Korean consortium to produce 100 mln doses a month of Russia’s Sputnik V vaccineSouth Korea’s Huons Global Co Ltd said on Friday it will lead a consortium to produce 100 million doses of Russia’s Sputnik V COVID-19 vaccine per ... Coronavirus
Iran finalizes purchase of 60 million Sputnik V COVID-19 vaccines from RussiaIran has finalized a deal with Russia to purchase 60 million doses of Sputnik V coronavirus vaccine, the state-run IRNA news agency reported on ... Coronavirus
India approves Sputnik V COVID-19 vaccineIndia has approved the use of Russian Sputnik V COVID-19 vaccine, the Russian Direct Investment Fund (RDIF) said on Monday, confirming earlier reports ... Coronavirus
Algeria will start producing Russia’s Sputnik V COVID-19 vaccine in SeptemberAlgeria will start producing Russia’s Sputnik V COVID-19 vaccine in September in partnership with Moscow, and part of the production will be intended ... Coronavirus